Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions.

Aldabe R, Suárez-Amarán L, Usai C, González-Aseguinolaza G.

Pathogens. 2015 Feb 12;4(1):46-65. doi: 10.3390/pathogens4010046. Review.

2.

Cold-preservation of human adult hepatocytes for liver cell therapy.

Duret C, Moreno D, Anangi B, Roux S, Briolotti P, Raulet E, Herrero A, Ramet H, Biron-Andreani C, Gerbal-Chaloin S, Ramos J, Navarro F, Hardwigsen J, Maurel P, Aldabe R, Daujat-Chavanieu M.

Cell Transplant. 2015 Jan 23. [Epub ahead of print]

PMID:
25622096
3.

Image analysis for the quantitative comparison of stress fibers and focal adhesions.

Elosegui-Artola A, Jorge-Peñas A, Moreno-Arotzena O, Oregi A, Lasa M, García-Aznar JM, De Juan-Pardo EM, Aldabe R.

PLoS One. 2014 Sep 30;9(9):e107393. doi: 10.1371/journal.pone.0107393. eCollection 2014.

4.

Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection.

Larrea E, Echeverria I, Riezu-Boj JI, Aldabe R, Guembe L, Sola I, Civeira MP, Sarobe P, Prieto J.

J Hepatol. 2014 Mar;60(3):482-9. doi: 10.1016/j.jhep.2013.10.016. Epub 2013 Oct 26.

PMID:
24418171
5.

Usage of adenovirus expressing thymidine kinase mediated hepatocellular damage for enabling mouse liver repopulation with allogenic or xenogenic hepatocytes.

Moreno D, Balasiddaiah A, Lamas O, Duret C, Neri L, Guembe L, Galarraga M, Larrea E, Daujat-Chavanieu M, Muntane J, Maurel P, Riezu JI, Prieto J, Aldabe R.

PLoS One. 2013 Sep 24;8(9):e74948. doi: 10.1371/journal.pone.0074948. eCollection 2013.

6.

Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes.

Larrea E, Riezu-Boj JI, Aldabe R, Guembe L, Echeverria I, Balasiddaiah A, Gastaminza P, Civeira MP, Sarobe P, Prieto J.

Gut. 2014 Apr;63(4):665-73. doi: 10.1136/gutjnl-2012-304377. Epub 2013 Jun 20.

PMID:
23787026
7.

Hepatic differentiation of mouse iPS cells and analysis of liver engraftment potential of multistage iPS progeny.

Balasiddaiah A, Moreno D, Guembe L, Prieto J, Aldabe R.

J Physiol Biochem. 2013 Dec;69(4):835-45. doi: 10.1007/s13105-013-0260-9. Epub 2013 May 30.

PMID:
23715756
8.

N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18.

9.

Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle.

Molina-Jimenez F, Benedicto I, Dao Thi VL, Gondar V, Lavillette D, Marin JJ, Briz O, Moreno-Otero R, Aldabe R, Baumert TF, Cosset FL, Lopez-Cabrera M, Majano PL.

Virology. 2012 Mar 30;425(1):31-9. doi: 10.1016/j.virol.2011.12.021. Epub 2012 Jan 24.

10.

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, Echeverria I, Sarobe P, Herrero I, Sangro B, Prieto J, Lasarte JJ.

J Hepatol. 2011 Mar;54(3):422-31. doi: 10.1016/j.jhep.2010.07.014. Epub 2010 Sep 26.

PMID:
21129807
11.

Characterization of the human Nalpha-terminal acetyltransferase B enzymatic complex.

Ametzazurra A, Gázquez C, Lasa M, Larrea E, Prieto J, Aldabe R.

BMC Proc. 2009 Aug 4;3 Suppl 6:S4. doi: 10.1186/1753-6561-3-S6-S4.

12.

The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.

Benedicto I, Molina-Jiménez F, Bartosch B, Cosset FL, Lavillette D, Prieto J, Moreno-Otero R, Valenzuela-Fernández A, Aldabe R, López-Cabrera M, Majano PL.

J Virol. 2009 Aug;83(16):8012-20. doi: 10.1128/JVI.00038-09. Epub 2009 Jun 10.

13.

Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.

Bortolanza S, Bunuales M, Alzuguren P, Lamas O, Aldabe R, Prieto J, Hernandez-Alcoceba R.

Cancer Gene Ther. 2009 Sep;16(9):703-12. doi: 10.1038/cgt.2009.12. Epub 2009 Feb 20.

PMID:
19229289
14.

Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells.

Larrea E, Aldabe R, Gonzalez I, Segura V, Sarobe P, Echeverria I, Prieto J.

J Virol. 2009 Apr;83(7):3298-311. doi: 10.1128/JVI.02167-08. Epub 2009 Jan 21.

15.

Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor.

Liu J, HuangFu WC, Kumar KG, Qian J, Casey JP, Hamanaka RB, Grigoriadou C, Aldabe R, Diehl JA, Fuchs SY.

Cell Host Microbe. 2009 Jan 22;5(1):72-83. doi: 10.1016/j.chom.2008.11.008.

16.

Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum.

Benedicto I, Molina-Jiménez F, Barreiro O, Maldonado-Rodríguez A, Prieto J, Moreno-Otero R, Aldabe R, López-Cabrera M, Majano PL.

Hepatology. 2008 Oct;48(4):1044-53. doi: 10.1002/hep.22465.

PMID:
18802961
17.

Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis.

Ametzazurra A, Larrea E, Civeira MP, Prieto J, Aldabe R.

Oncogene. 2008 Dec 11;27(58):7296-306. doi: 10.1038/onc.2008.332. Epub 2008 Sep 15.

PMID:
18794801
18.

HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway.

Luquin E, Larrea E, Civeira MP, Prieto J, Aldabe R.

Antiviral Res. 2007 Nov;76(2):194-7. Epub 2007 Aug 6.

PMID:
17675168
19.

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Larrea E, Riezu-Boj JI, Gil-Guerrero L, Casares N, Aldabe R, Sarobe P, Civeira MP, Heeney JL, Rollier C, Verstrepen B, Wakita T, Borrás-Cuesta F, Lasarte JJ, Prieto J.

J Virol. 2007 Apr;81(7):3662-6. Epub 2007 Jan 17.

20.

Gene therapy for viral hepatitis.

Gonzalez-Aseguinolaza G, Crettaz J, Ochoa L, Otano I, Aldabe R, Paneda A.

Expert Opin Biol Ther. 2006 Dec;6(12):1263-78. Review.

PMID:
17223736
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk